bpc 157 injection protocol Exciting news for peptides coming out of today's committee hearing! The FDA Pharmacy Compounding Advisory Committee voted 8-6 to recommend adding BPC- to the 503A Bulks List for use in compounding for bpc-157 oral vs injection absorption

Oral GHK-Cu dosing research considers bioavailability differently than injectable research, because oral administration involves gastrointestinal processing before systemic distribution

Regulatory status: Neither peptide is FDA-approved, and both are banned for competitive athletes by WADA

Closure of the neural tube occurs very early in pregnancy, by the sixth week of gestation, a time when many women do not realize they are pregnant

It was added to the Prohibited List in 2022 as a non-approved substance, reflecting its transition from an obscure research compound to a significant "substance of interest" in professional athletics